The polyphenol epigallocatechin-3-gallate affects lipid rafts to block activation of the c-Met receptor in prostate cancer cells

Molecular Carcinogenesis

Volumn 49, Issue 8, 2010, Pages 739-749

  Duhon, Damian ^a   Bigelow, Rebecca L H ^a   Coleman, David T ^a   Steffan, Joshua J ^a   Yu, Chris ^a   Langston, Will ^b   Kevil, Christopher G ^a,b   Cardelli, James A ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

c Met; EGCG; Lipid rafts; Prostate cancer; Signaling

Indexed keywords

CHOLESTEROL; EPIGALLOCATECHIN GALLATE; METHYL BETA CYCLODEXTRIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; TRITON X 100; UVOMORULIN;

ARTICLE; CANCER CELL; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; DIMERIZATION; HUMAN; HUMAN CELL; LIPID RAFT; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION;

ANTICARCINOGENIC AGENTS; ANTIOXIDANTS; BETA-CYCLODEXTRINS; CATECHIN; CELL MOVEMENT; CELLS; FLAVONOIDS; HUMANS; MALE; OCTOXYNOL; PHENOLS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TEA;

EID: 77956162212     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20649     Document Type: Article

References (35)

1. Trusolino L, Comoglio PM. Scatter-factor and semaphorin receptors: Cell signalling for invasive growth. Nat Rev Cancer 2002;2:289-300.
2. Knudsen BS, Gmyrek GA, Inra J, et al. High expression of the Met receptor in prostate cancer metastasis to bone. Urology 2002;60:1113-1117.
3. Nakashiro K, Hayashi Y, Oyasu R. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue. Oncol Rep 2003;10:1149-1153.
4. Naughton M, Picus J, Zhu X, et al. Scatter factor-hepatocyte growth factor elevation in the serum of patients with prostate cancer. J Urol 2001;165:1325-1328. (Pubitemid 32210284)
5. Humphrey PA, Halabi S, Picus J, et al. Prognostic significance of plasma scatter factor/hepatocyte growth factor levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 150005/9480. Clin Genitourin Cancer 2006;4:269-274.
6. Nakashiro K, Hara S, Shinohara Y, et al. Phenotypic switch from paracrine to autocrine role of hepatocyte growth factor in an androgen-independent human prostatic carcinoma cell line, CWR22R. Am J Pathol 2004;165:533-540.
7. Comoglio PM, Giordano S, Trusolino L. Drug development of MET inhibitors: Targeting oncogene addiction and expedience. Nat Rev Drug Discov 2008;7:504-516. (Pubitemid 351767118)
8. Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr 2003;133:3262S-3267S.
9. Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3- gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem 2004;279:12755-12762.
10. Yang CS, Lambert JD, Ju J, Lu G, Sang S. Tea and cancer prevention: Molecular mechanisms and human relevance. Toxicol Appl Pharmacol 2007;224:265-273.
11. Chow HH, Cai Y, Alberts DS, et al. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 2001;10:53-58.
12. Chow HH, Cai Y, Hakim IA, et al. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003;9:3312-3319.
13. Thomasset SC, Berry DP, Garcea G, et al. Dietary polyphenolic phytochemicals - Promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 2007;120:451-458. (Pubitemid 44969013)
14. Bettuzzi S, Brausi M, Rizzi F, et al. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: A preliminary report from a one-year proof-of-principle study. Cancer Res 2006;66:1234-1240.
15. McLarty J, Bigelow RL, Smith M, et al. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev Res 2009;2:673-682.
16. Bigelow RL, Cardelli JA. The green tea catechins, (-)-epigallocatechin-3- gallate (EGCG) and (-)-epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells. Oncogene 2006;25:1922-1930.
17. Milligan SA, Burke P, Coleman DT, et al. The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells. Clin Cancer Res 2009;15:4885-4894.
18. Solomon KR, Mallory MA, Hanify KA, Finberg RW. The nature of membrane anchorage determines kinase association and detergent solubility of CD4. Biochem Biophys Res Commun 1998;242:423-428.
19. Patra SK, Rizzi F, Silva A, Rugina DO, Bettuzzi S. Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): Specificity and interaction with membrane lipid rafts. J Physiol Pharmacol 2008;59:217-235.
20. Adachi S, Nagao T, Ingolfsson HI, et al. The inhibitory effect of (-)-epigallocatechin gallate on activation of the epidermal growth factor receptor is associated with altered lipid order in HT29 colon cancer cells. Cancer Res 2007;67:6493-6501.
21. Stehr M, Adam RM, Khoury J, et al. Platelet derived growth factor-BB is a potent mitogen for rat ureteral and human bladder smooth muscle cells: Dependence on lipid rafts for cell signaling. J Urol 2003;169:1165-1170.
22. Fujimura Y, Tachibana H, Yamada K. Lipid raft-associated catechin suppresses the FcepsilonRI expression by inhibiting phosphorylation of the extracellular signal-regulated kinase1/2. FEBS Lett 2004;556:204-210. (Pubitemid 38058580)
23. Shimizu M, Deguchi A, Lim JT, et al. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res 2005;11:2735-2746.
24. Nijveldt RJ, van Nood E, van Hoorn DE, et al. Flavonoids: A review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001;74:418-425.
25. Katiyar SK, Afaq F, Azizuddin K, Mukhtar H. Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratinocytes by green tea polyphenol (-)-epigallocatechin-3-gallate. Toxicol Appl Pharmacol 2001;176:110-117.
26. Yang GY, Liao J, Li C, et al. Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: Possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 2000;21:2035-2039.
27. Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998;19:611-616.
28. Le Roy C, Wrana JL. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 2005;6:112-126.
29. Zhuang L, Kim J, Adam RM, Solomon KR, Freeman MR. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 2005;115:959-968.
30. Hong S, Huo H, Xu J, Liao K. Insulin-like growth factor-1 receptor signaling in 3T3-L1 adipocyte differentiation requires lipid rafts but not caveolae. Cell Death Differ 2004;11:714-723. (Pubitemid 39023118)
31. Chen A, Zhang L. The antioxidant (-)-epigallocatechin-3-gallate inhibits rat hepatic stellate cell proliferation in vitro by blocking the tyrosine phosphorylation and reducing the gene expression of platelet-derived growth factor-beta receptor. J Biol Chem 2003;278:23381-23389.
32. Shimizu M, Deguchi A, Hara Y, Moriwaki H, Weinstein IB. EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem Biophys Res Commun 2005;334:947-953. (Pubitemid 41033211)
33. Tachibana H, Koga K, Fujimura Y, Yamada K. A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 2004;11:380-381.
34. Ermakova S, Choi BY, Choi HS, et al. The intermediate filament protein vimentin is a new target for epigallocatechin gallate. J Biol Chem 2005;280:16882-16890. (Pubitemid 41389147)
35. Runembert I, Queffeulou G, Federici P, et al. Vimentin affects localization and activity of sodium-glucose cotransporter SGLT1 in membrane rafts. J Cell Sci 2002;115:713-724. (Pubitemid 34196331)